Successful Clonazepam Treatment of Neuroleptic-Induced Akathisia in Older Adolescents and Young Adults
STAN KUTCHER, PETER WILLIAMSON, SUSAN MACKENZIE, PETER MARTON, MURRAY EHRLICH
Abstract
STAN KUTCHER, PETER WILLIAMSON, SUSAN MACKENZIE, PETER MARTON, MURRAY EHRLICH
Abstract
In a double-blind, placebo-controlled trial of clonazepam in the treatment of neuroleptic-induced akathisia in older adolescents, clonazepam was significantly more effective at reducing akathisia scores at the end of the first treatment week than placebo (p < 0.0001). Clonazepam may be a safe and effective treatment for neuroleptic-induced akathisia in this age group.
OpenAlex reports 40 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In a double-blind, placebo-controlled trial of clonazepam in the treatment of neuroleptic-induced akathisia in older adolescents, clonazepam was significantly more effective at reducing akathisia scores at the end of the first treatment week than placebo (p < 0.0001). Clonazepam may be a safe and effective treatment for neuroleptic-induced akathisia in this age group.
Key concepts: Clonazepam, Akathisia, Placebo, Medicine, Anesthesia, Psychology, Psychiatry, Antipsychotic